PRESS RELEASE published on 04/04/2025 at 08:00, 1 year 3 months ago Transaction in Own Shares Molten Ventures plc (GROW; GRW) announces the purchase of 70,000 Ordinary Shares at varying prices as part of the share repurchase program. Details of individual transactions provided Molten Ventures Plc GROW GRW Transaction Details Share Repurchase Program
BRIEF published on 04/03/2025 at 08:05, 1 year 3 months ago Molten Ventures Executes Share Buyback Voting Rights Share Repurchase Ordinary Shares Numis Securities Molten Ventures
BRIEF published on 04/03/2025 at 08:05, 1 year 3 months ago Molten Ventures procède à un rachat d'actions Rachat D'actions Droit De Vote Actions Ordinaires Numis Securities Molten Ventures
PRESS RELEASE published on 04/03/2025 at 08:00, 1 year 3 months ago Transaction in Own Shares Molten Ventures Plc (GROW; GRW) announces the purchase of 51,553 of its Ordinary Shares as part of a share repurchase program. Numis Securities Limited facilitated the transactions Molten Ventures Plc Numis Securities Limited GROW GRW Share Repurchase Program
BRIEF published on 04/02/2025 at 08:05, 1 year 3 months ago Molten Ventures Plc Executes Share Repurchase Share Repurchase Ordinary Shares Numis Securities Molten Ventures Capital Management
BRIEF published on 04/02/2025 at 08:05, 1 year 3 months ago Molten Ventures Plc exécute un rachat d'actions Rachat D'actions Actions Ordinaires Numis Securities Gestion Du Capital Entreprises En Fusion
PRESS RELEASE published on 04/02/2025 at 08:00, 1 year 3 months ago Transaction in Own Shares Molten Ventures plc announces purchase of 70,000 ordinary shares on 1 April 2025 through share repurchase program. Details of transaction prices and volume included Ordinary Shares Molten Ventures Plc Numis Securities Limited Share Purchase Repurchase Program
BRIEF published on 04/01/2025 at 08:35, 1 year 3 months ago Molten Ventures Announces Total Voting Rights Update Ordinary Shares Total Voting Rights Venture Capital Molten Ventures Transparency Regulations
BRIEF published on 04/01/2025 at 08:35, 1 year 3 months ago Molten Ventures annonce une mise à jour du total des droits de vote Actions Ordinaires Capital-risque Règlement Sur La Transparence Entreprises En Fusion Total Des Droits De Vote
PRESS RELEASE published on 04/01/2025 at 08:30, 1 year 3 months ago Total Voting Rights Molten Ventures Plc announces total voting rights as at 31 March 2025. Shareholders can use 184,174,683 as the denominator for interest notifications under DTRs Shareholders Ordinary Shares Molten Ventures Plc Total Voting Rights DTRs
Published on 07/31/2026 at 01:39, 4 hours 54 minutes ago Transition from OTCQB to Unsponsored OTC Quotation
Published on 07/30/2026 at 23:45, 6 hours 48 minutes ago Namibia Critical Metals Announces Completion of Japan's C$23 Million Earn-In and Formation of Strategic Joint Venture Company for the Lofdal Heavy Rare Earth Project
Published on 07/30/2026 at 23:01, 7 hours 32 minutes ago Pinetree Capital Announces Unaudited Financial Results for the Period Ended June 30, 2026 and Management Changes
Published on 07/30/2026 at 23:00, 7 hours 33 minutes ago Eagle Plains Announces Approval of Warrant Expiry Extension
Published on 07/30/2026 at 18:52, 11 hours 41 minutes ago First Canadian Graphite annonce des résultats de prospection de graphite à haute teneur jusqu'à 43,4 % Cg au projet Lac Guéret Sud
Published on 07/31/2026 at 00:00, 6 hours 33 minutes ago EQS-Adhoc: VIB Vermögen AG: Agreements on the restructuring of financial liabilities of BRANICKS Group AG signed, incl. commitment for a € 60 mn financing for VIB Vermögen AG
Published on 07/30/2026 at 23:48, 6 hours 44 minutes ago BRANICKS Group AG Reaches Comprehensive Restructuring Agreement with Its Creditors
Published on 07/30/2026 at 23:46, 6 hours 47 minutes ago EQS-Adhoc: Branicks Group AG: BRANICKS Group AG Reaches Comprehensive Restructuring Agreement with Its Creditors
Published on 07/30/2026 at 22:05, 8 hours 28 minutes ago Abivax Announces Positive Pre-NDA Interaction with the FDA for Obefazimod
Published on 07/30/2026 at 22:05, 8 hours 28 minutes ago Abivax annonce un retour positif de la FDA à l’issue de ses échanges pré-NDA concernant l’obéfazimod
Published on 07/30/2026 at 18:15, 12 hours 17 minutes ago Publication of the 2026 half-year financial report
Published on 07/30/2026 at 18:15, 12 hours 17 minutes ago Mise à disposition du rapport financier semestriel au 30 juin 2026
Published on 07/30/2026 at 18:05, 12 hours 28 minutes ago Electricité de Strasbourg - Avis de mise à disposition de l'information financière du 1er semestre 2026
